These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 23645748
21. Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation. van Iersel LB, Verlaan MR, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Sparidans RW, Gelderblom H, Kuppen PJ, Tollenaar RA, van de Velde CJ. Eur J Surg Oncol; 2007 Sep; 33(7):874-81. PubMed ID: 17400422 [Abstract] [Full Text] [Related]
22. Chemosaturation with percutaneous hepatic perfusion is effective in patients with ocular melanoma and cholangiocarcinoma. Schönfeld L, Hinrichs JB, Marquardt S, Voigtländer T, Dewald C, Koppert W, Manns MP, Wacker F, Vogel A, Kirstein MM. J Cancer Res Clin Oncol; 2020 Nov; 146(11):3003-3012. PubMed ID: 32564137 [Abstract] [Full Text] [Related]
23. Apoptosis induced by 5-fluorouracil, cisplatin and paclitaxel are associated with p53 gene status in gastric cancer cell lines. Matsuhashi N, Saio M, Matsuo A, Sugiyama Y, Saji S. Int J Oncol; 2005 Jun; 26(6):1563-7. PubMed ID: 15870870 [Abstract] [Full Text] [Related]
24. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines. Tanaka R, Ariyama H, Qin B, Takii Y, Baba E, Mitsugi K, Harada M, Nakano S. Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917 [Abstract] [Full Text] [Related]
25. Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival. Marquardt S, Kirstein MM, Brüning R, Zeile M, Ferrucci PF, Prevoo W, Radeleff B, Trillaud H, Tselikas L, Vicente E, Wiggermann P, Manns MP, Vogel A, Wacker FK. Eur Radiol; 2019 Apr; 29(4):1882-1892. PubMed ID: 30255257 [Abstract] [Full Text] [Related]
26. In vitro cytotoxicity of cyclodextrin-bonded birch bark extract. Hertrampf A, Gründemann C, Jäger S, Laszczyk M, Giesemann T, Huber R. Planta Med; 2012 Jun; 78(9):881-9. PubMed ID: 22573365 [Abstract] [Full Text] [Related]
33. Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro. Michalakis J, Georgatos SD, de Bree E, Polioudaki H, Romanos J, Georgoulias V, Tsiftsis DD, Theodoropoulos PA. Ann Surg Oncol; 2007 Mar; 14(3):1220-8. PubMed ID: 17206477 [Abstract] [Full Text] [Related]
35. Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure. Failli A, Consolini R, Legitimo A, Orsini G, Romanini A, Spisni R, Castagna M, Miccoli P. J Biol Regul Homeost Agents; 2011 Mar; 25(4):575-88. PubMed ID: 22217990 [Abstract] [Full Text] [Related]
36. Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations. Miao N, Pingpank JF, Alexander HR, Steinberg SM, Beresneva T, Quezado ZM. Ann Surg Oncol; 2008 Mar; 15(3):815-23. PubMed ID: 18180999 [Abstract] [Full Text] [Related]
37. p53 dependent and independent sensitivity to oxaliplatin of colon cancer cells. Toscano F, Parmentier B, Fajoui ZE, Estornes Y, Chayvialle JA, Saurin JC, Abello J. Biochem Pharmacol; 2007 Aug 01; 74(3):392-406. PubMed ID: 17559811 [Abstract] [Full Text] [Related]
38. [A 5-FU, ADR, MMC combined hepatic arterial infusion therapy in non-resectable liver metastases from colon and gastric cancer]. Arai Y, Endo T, Miyake Y, Sakamoto K, Kido C. Gan To Kagaku Ryoho; 1989 Aug 01; 16(8 Pt 2):2731-4. PubMed ID: 2782885 [Abstract] [Full Text] [Related]